• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过学校定位接种计划为从未接种过流感疫苗的儿童接种疫苗。

Reaching children never previously vaccinated for influenza through a school-located vaccination program.

机构信息

Susan M. Kansagra, Vikki Papadouka, Anita Geevarughese, and Kevin J. Konty are with and Michael A. Hansen was with the New York City Department of Health and Mental Hygiene, New York City, NY. Jane R. Zucker is with the Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, assigned to the Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, NY.

出版信息

Am J Public Health. 2014 Jan;104(1):e45-9. doi: 10.2105/AJPH.2013.301671. Epub 2013 Nov 14.

DOI:10.2105/AJPH.2013.301671
PMID:24228652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3910058/
Abstract

OBJECTIVES

We determined the success of the school-located vaccination (SLV) program, implemented in 2009 in New York City to deliver pandemic influenza A (H1N1) monovalent vaccine (pH1N1), versus provider offices in reaching children who had never previously received influenza vaccine.

METHODS

We compared the immunization history of children vaccinated in school versus provider offices. We included records in the Citywide Immunization Registry with pH1N1 administered between October 2009 and March 2010 to elementary school-aged children.

RESULTS

In total, 96,524 children received pH1N1 vaccine in schools, and 102,933 children received pH1N1 vaccine in provider offices. Of children vaccinated in schools, 34% had never received seasonal influenza vaccination in the past, compared with only 10% of children vaccinated at provider offices (P < .001). Children vaccinated in schools were more likely to have received a second dose of pH1N1 in 2009-2010 than those vaccinated in provider offices (80% vs 45%).

CONCLUSIONS

The SLV program was more successful at reaching children who had never received influenza immunization in the past and should be considered as a strategy for delivering influenza vaccine in routine and emergency situations.

摘要

目的

我们旨在确定 2009 年在纽约市实施的学校定位疫苗接种(SLV)计划的成功情况,该计划旨在提供大流行性流感 A(H1N1)单价疫苗(pH1N1),以与医疗服务提供者办公室在为从未接受过流感疫苗的儿童接种疫苗方面进行比较。

方法

我们比较了在学校和医疗服务提供者办公室接种疫苗的儿童的免疫接种史。我们将 2009 年 10 月至 2010 年 3 月期间在全市免疫登记处记录的 pH1N1 接种给小学年龄的儿童纳入研究。

结果

共有 96524 名儿童在学校接种了 pH1N1 疫苗,102933 名儿童在医疗服务提供者办公室接种了 pH1N1 疫苗。在学校接种疫苗的儿童中,34%的儿童过去从未接种过季节性流感疫苗,而在医疗服务提供者办公室接种疫苗的儿童中,这一比例仅为 10%(P <.001)。与在医疗服务提供者办公室接种疫苗的儿童相比,在学校接种疫苗的儿童在 2009-2010 年更有可能接种第二剂 pH1N1 疫苗(80%对 45%)。

结论

SLV 计划在为过去从未接受过流感免疫的儿童接种疫苗方面更成功,应考虑将其作为在常规和紧急情况下提供流感疫苗的策略。

相似文献

1
Reaching children never previously vaccinated for influenza through a school-located vaccination program.通过学校定位接种计划为从未接种过流感疫苗的儿童接种疫苗。
Am J Public Health. 2014 Jan;104(1):e45-9. doi: 10.2105/AJPH.2013.301671. Epub 2013 Nov 14.
2
Factors associated with receipt of 2009 pandemic influenza A (H1N1) monovalent and seasonal influenza vaccination among school-aged children: Maricopa County, Arizona, 2009-2010 influenza season.与 2009 年甲型 H1N1 流感大流行单克隆疫苗和季节性流感疫苗在学龄儿童中接种相关的因素:亚利桑那州马里科帕县,2009-2010 年流感季节。
J Public Health Manag Pract. 2013 Sep-Oct;19(5):436-43. doi: 10.1097/PHH.0b013e3182751d1c.
3
Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.小学流感疫苗接种项目第二年的成本效益分析——一项随机对照试验的结果
BMC Health Serv Res. 2015 Nov 16;15:511. doi: 10.1186/s12913-015-1169-5.
4
Description of a large urban school-located 2009 pandemic H1N1 vaccination campaign, New York City 2009-2010.描述 2009-2010 年纽约市大型城市学校定位 2009 年大流行性 H1N1 疫苗接种运动。
J Urban Health. 2012 Apr;89(2):317-28. doi: 10.1007/s11524-011-9640-z.
5
Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years.2009 年甲型 H1N1 流感疫苗 1 剂接种对预防 7 月龄-9 岁儿童因大流行 H1N1 流感住院的效果。
J Infect Dis. 2012 Jul 1;206(1):49-55. doi: 10.1093/infdis/jis306. Epub 2012 May 2.
6
Evaluating the most effective distribution strategies to assure administration of pandemic H1N1 influenza vaccine to New York State children and adolescents: evaluation using the New York State Immunization Information System.评估确保纽约州儿童和青少年接种大流行性 H1N1 流感疫苗的最有效分发策略:利用纽约州免疫信息系统进行评估。
J Public Health Manag Pract. 2013 Nov-Dec;19(6):589-97. doi: 10.1097/PHH.0b013e31828002af.
7
Parental perceptions and predictors of consent for school-located influenza vaccination in urban elementary school children in the United States.美国城市小学儿童家长对学校流感疫苗接种同意的认知及预测因素
Influenza Other Respir Viruses. 2015 Sep;9(5):255-62. doi: 10.1111/irv.12332.
8
School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance.学校流感疫苗接种可减少实验室确诊的流感病例,并提高学校出勤率。
Clin Infect Dis. 2014 Aug 1;59(3):325-32. doi: 10.1093/cid/ciu340. Epub 2014 May 14.
9
Multicomponent interventions to enhance influenza vaccine delivery to adolescents.多组分干预措施以增强青少年流感疫苗的接种率。
Pediatrics. 2011 Nov;128(5):e1092-9. doi: 10.1542/peds.2011-0453. Epub 2011 Oct 10.
10
Quadrivalent Live-Attenuated Influenza Vaccine in Milan preschools: an Italian experience of school-located flu vaccination within the 2022-2023 season.米兰幼儿园四价流感减毒活疫苗:意大利在 2022-2023 季节期间在学校进行流感疫苗接种的经验。
Ital J Pediatr. 2024 May 13;50(1):97. doi: 10.1186/s13052-024-01649-2.

引用本文的文献

1
Exploring Demographic Disparities in Private Well Water Testing in North Carolina.探索北卡罗来纳州私人井水检测中的人口差异。
Environ Sci Technol. 2025 Jan 21;59(2):1232-1242. doi: 10.1021/acs.est.4c05437. Epub 2025 Jan 9.
2
Quadrivalent Live-Attenuated Influenza Vaccine in Milan preschools: an Italian experience of school-located flu vaccination within the 2022-2023 season.米兰幼儿园四价流感减毒活疫苗:意大利在 2022-2023 季节期间在学校进行流感疫苗接种的经验。
Ital J Pediatr. 2024 May 13;50(1):97. doi: 10.1186/s13052-024-01649-2.
3
Parents and teachers' perspectives on a school-located influenza vaccination program: A pilot study in the Region of Murcia, Spain.家长和教师对学校定位流感疫苗接种计划的看法:西班牙穆尔西亚地区的一项试点研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2328406. doi: 10.1080/21645515.2024.2328406. Epub 2024 Apr 4.
4
Preschool-located influenza vaccination and influenza-like illness surveillance: an Italian pilot experience.幼儿园内接种流感疫苗和流感样疾病监测:意大利的一项试点经验。
Ital J Pediatr. 2023 Jul 21;49(1):91. doi: 10.1186/s13052-023-01481-0.
5
[Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra].[针对意大利儿童使用四价流感裂解疫苗(Fluenz Tetra)接种流感疫苗的卫生技术评估]
J Prev Med Hyg. 2021 Sep 10;62(2 Suppl 1):E1-E118. doi: 10.15167/2421-4248/jpmh2021.62.2s1. eCollection 2021 Jun.
6
Countering vaccine hesitancy through immunization information systems, a narrative review.通过免疫信息系统应对疫苗犹豫:叙事性综述。
Hum Vaccin Immunother. 2019;15(11):2508-2526. doi: 10.1080/21645515.2019.1599675. Epub 2019 Jun 21.
7
Are we speaking the same language? an argument for the consistent use of terminology and definitions for childhood vaccination indicators.我们说的是同一种语言吗? 一个关于儿童疫苗接种指标术语和定义一致使用的论据。
Hum Vaccin Immunother. 2019;15(3):740-747. doi: 10.1080/21645515.2018.1546526. Epub 2018 Dec 20.
8
Use of Medical Countermeasures in Small-Scale Emergency Responses.在小规模应急响应中使用医疗对策。
Am J Public Health. 2018 Sep;108(S3):S196-S201. doi: 10.2105/AJPH.2018.304491.
9
Studies evaluating of health interventions at schools: an integrative literature review.学校健康干预措施的评估研究:一项综合文献综述。
Rev Lat Am Enfermagem. 2018 Jul 16;26:e3008. doi: 10.1590/1518-8345.2463.3008.
10
Implementing a School-Located Vaccination Program in Denver Public Schools.在丹佛公立学校实施校内疫苗接种计划。
J Sch Health. 2015 Aug;85(8):536-43. doi: 10.1111/josh.12281.

本文引用的文献

1
Cost comparison of 2 mass vaccination campaigns against influenza A H1N1 in New York City.纽约市两次甲型 H1N1 流感大规模疫苗接种活动的成本比较。
Am J Public Health. 2012 Jul;102(7):1378-83. doi: 10.2105/AJPH.2011.300363. Epub 2011 Dec 15.
2
Description of a large urban school-located 2009 pandemic H1N1 vaccination campaign, New York City 2009-2010.描述 2009-2010 年纽约市大型城市学校定位 2009 年大流行性 H1N1 疫苗接种运动。
J Urban Health. 2012 Apr;89(2):317-28. doi: 10.1007/s11524-011-9640-z.
3
Vaccination coverage among U.S. children aged 19-35 months entitled by the Vaccines for Children program, 2009.2009 年美国儿童疫苗计划(Vaccines for Children program)覆盖的 19-35 个月龄儿童疫苗接种率。
Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):109-23. doi: 10.1177/00333549111260S213.
4
Protecting the Public from H1N1 through Points of Dispensing (PODs).通过分发点(PODs)保护公众免受甲型H1N1流感侵害。
Biosecur Bioterror. 2011 Mar;9(1):13-21. doi: 10.1089/bsp.2010.0049. Epub 2011 Mar 1.
5
Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial.儿童流感疫苗接种对胡特尔社区感染率的影响:一项随机试验。
JAMA. 2010 Mar 10;303(10):943-50. doi: 10.1001/jama.2010.250.
6
Statewide school-located influenza vaccination program for children 5-13 years of age, Hawaii, USA.美国夏威夷州为 5-13 岁儿童实施的全州校园流感疫苗接种计划。
Emerg Infect Dis. 2010 Feb;16(2):244-50. doi: 10.3201/eid1602.091375.
7
Using an immunization information system to improve accountability for vaccines distributed through the Vaccines for Children program in New York City, 2005-2008.利用免疫信息系统提高2005 - 2008年纽约市通过儿童疫苗计划分发的疫苗的问责制。
J Public Health Manag Pract. 2009 Sep-Oct;15(5):E13-21. doi: 10.1097/PHH.0b013e3181a8c31f.
8
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.《用疫苗预防和控制季节性流感:免疫实践咨询委员会(ACIP)的建议,2009年》
MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1-52.
9
The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly.儿童大规模流感免疫接种对未接种疫苗的老年人发病率的影响。
Epidemiol Infect. 2006 Feb;134(1):71-8. doi: 10.1017/S0950268805005650. Epub 2005 Nov 29.
10
Population-wide benefits of routine vaccination of children against influenza.儿童常规接种流感疫苗对全人群的益处。
Vaccine. 2005 Jan 26;23(10):1284-93. doi: 10.1016/j.vaccine.2004.08.044.